SEC Form D filing

Elucid Bioimaging Inc., 2025-10-22

An SEC Form D private-offering notice from Boston, MA, a $79,999,999 filer-stated offering target in Biotech. Filed 2025-10-22. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Elucid Bioimaging Inc. site↗ Verified via SEC Form D

Developer of Plaque IQ, an FDA cleared AI software that analyzes CT angiography scans to assess arterial plaque and cardiovascular risk

Filed 2025-10-22Filed to raise $79,999,999First money in 2025-10-10Raised so far $36,495,008HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified elucid.com↗Named in the filing 8 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source